3.19

3.04% -0.10

After Hours: 3.19

Personalis Inc (PSNL)

Overview News Price History Option Chain Financials Discussions Forecast

Personalis Inc stock is traded at $3.19, with a volume of 695.18K. It is down -3.04% in the last 24 hours and down -16.05% over the past month. Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

Previous Close:

$3.29

Open:

$3.3

24h Volume:

695.18K

Relative Volume:

0.70

Market Cap:

$286.12M

Revenue:

$73.48M

Net Income/Loss:

$-108.30M

P/E Ratio:

-1.4178

EPS:

-2.25

Net Cash Flow:

$-67.17M

1W Performance:

+5.28%

1M Performance:

-16.05%

6M Performance:

-30.95%

1Y Performance:

+165.83%

1-Day Range:

$3.10

$3.3286

1-Week Range:

$2.96

$3.40

52-Week Range:

$1.135

$7.20

Personalis Inc Stock (PSNL) Company Profile

Name

Personalis Inc

Sector

Healthcare (1151)

Industry

Diagnostics & Research (58)

Phone

650-752-1300

Address

6600 DUMBARTON CIRCLE, FREMONT, CA

Employee

229

Twitter

@PersonalisInc

Next Earnings Date

2024-11-06

Latest SEC Filings

PSNL's Discussions on Twitter

Compare PSNL with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PSNL Personalis Inc	3.19	286.12M	73.48M	-108.30M	-67.17M	-2.25
TMO Thermo Fisher Scientific Inc	427.50	169.62B	42.88B	6.34B	7.27B	16.53
DHR Danaher Corp	186.83	138.06B	23.88B	3.90B	5.30B	5.28
IDXX Idexx Laboratories Inc	411.49	32.79B	3.90B	887.87M	798.08M	10.67
A Agilent Technologies Inc	102.48	29.99B	6.53B	1.26B	1.31B	4.35
IQV Iqvia Holdings Inc	143.91	26.61B	15.41B	1.37B	2.11B	7.50

Personalis Inc Stock (PSNL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-17-25	Initiated	Craig Hallum	Buy
Feb-06-23	Upgrade	Needham	Hold → Buy
Jan-07-22	Upgrade	BofA Securities	Neutral → Buy
Nov-05-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Nov-03-21	Downgrade	Needham	Buy → Hold
Oct-15-21	Resumed	Cowen	Outperform
Sep-20-21	Reiterated	Needham	Buy
May-06-21	Upgrade	Oppenheimer	Perform → Outperform
Jan-28-21	Initiated	Truist	Buy
Jan-04-21	Downgrade	BofA Securities	Buy → Neutral
Nov-12-20	Reiterated	Needham	Buy
Nov-06-20	Downgrade	Oppenheimer	Outperform → Perform
Oct-19-20	Initiated	Citigroup	Buy
Oct-08-20	Initiated	BTIG Research	Buy
Aug-27-20	Initiated	H.C. Wainwright	Buy
Aug-18-20	Initiated	Needham	Buy
Sep-26-19	Upgrade	BofA/Merrill	Neutral → Buy
Jul-15-19	Initiated	BofA/Merrill	Neutral
Jul-15-19	Initiated	Cowen	Outperform
Jul-15-19	Initiated	Morgan Stanley	Overweight
Jul-15-19	Initiated	Oppenheimer	Outperform

View All

Personalis Inc Stock (PSNL) Latest News

Apr 15, 2025

Arrowstreet Capital Limited Partnership Lowers Stock Holdings in Personalis, Inc. (NASDAQ:PSNL) - Defense World

Apr 15, 2025

Apr 14, 2025

Raymond James Financial Inc. Buys New Stake in Personalis, Inc. (NASDAQ:PSNL) - Defense World

Apr 14, 2025

American Century Companies Inc. Buys 25,011 Shares of Personalis, Inc. (NASDAQ:PSNL) - Defense World

Apr 14, 2025

Apr 12, 2025

Needham & Company LLC Reiterates “Buy” Rating for Personalis (NASDAQ:PSNL) - Defense World

Apr 12, 2025

Apr 11, 2025

With 33% stake, Personalis, Inc. (NASDAQ:PSNL) seems to have captured institutional investors' interest - Yahoo Finance

Apr 11, 2025

Apr 10, 2025

What 5 Analyst Ratings Have To Say About Personalis - Benzinga

Apr 10, 2025

Mar 26, 2025

Personalis to Participate at the 24th Annual Needham Virtual Healthcare Conference - BioSpace

Mar 26, 2025

Mar 23, 2025

Personalis, Inc. (NASDAQ:PSNL) Shares Sold by Connor Clark & Lunn Investment Management Ltd. - Defense World

Mar 23, 2025

Mar 22, 2025

Personalis Inc’s (PSNL) Stock Is Harder To Predict Than You Think - Stocks Register

Mar 22, 2025

Mar 21, 2025

What You Can Learn From Personalis, Inc.'s (NASDAQ:PSNL) P/S After Its 40% Share Price Crash - simplywall.st

Mar 21, 2025

Mar 20, 2025

Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Mar 20, 2025

Mar 18, 2025

Personalis (NASDAQ:PSNL) Now Covered by Craig Hallum - Defense World

Mar 18, 2025

Mar 17, 2025

Craig-Hallum Initiates Coverage of Personalis (PSNL) with Buy Recommendation - Nasdaq

Mar 17, 2025

This Blueprint Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Mar 17, 2025

Craig Hallum Initiates Coverage on Personalis With Buy Rating, $8 Price Target -March 17, 2025 at 07:58 am EDT - Marketscreener.com

Mar 17, 2025

Mar 12, 2025

Hold Rating for Personalis: Balancing Strong Enterprise Sales and Future Uncertainties - TipRanks

Mar 12, 2025

Mar 08, 2025

Cathie Wood-Led Ark Invest Roblox, Roku, UiPath As Markets Take A Dip - Benzinga

Mar 08, 2025

Mar 07, 2025

Personalis Stock Price, Quotes and Forecasts | NASDAQ:PSNL - Benzinga

Mar 07, 2025

Mar 03, 2025

Personalis stock target cut to $7 by BTIG, maintains Buy rating - Investing.com Canada

Mar 03, 2025

New Publication from ICR and Royal Marsden Researchers Highlights the Importance of Ultra-Sensitive ctDNA Testing for Early-Stage Breast Cancer Recurrence Detection - Yahoo Finance

Mar 03, 2025

Personalis’ (PSNL) “Buy” Rating Reiterated at HC Wainwright - Defense World

Mar 03, 2025

Needham & Company LLC Cuts Personalis (NASDAQ:PSNL) Price Target to $7.00 - Defense World

Mar 03, 2025

Mar 02, 2025

Personalis, Inc. (NASDAQ:PSNL) Just Reported Earnings, And Analysts Cut Their Target Price - Simply Wall St

Mar 02, 2025

Mar 01, 2025

Personalis (NASDAQ:PSNL) Price Target Lowered to $7.00 at Needham & Company LLC - MarketBeat

Mar 01, 2025

Personalis Full Year 2024 Earnings: Beats Expectations - Yahoo Finance UK

Mar 01, 2025

Feb 28, 2025

Personalis (NASDAQ:PSNL) Announces Quarterly Earnings Results - MarketBeat

Feb 28, 2025

Personalis stock target cut to $7.00 at Needham, retains buy rating By Investing.com - Investing.com South Africa

Feb 28, 2025

Personalis (NASDAQ:PSNL) Announces Earnings Results, Beats Expectations By $0.09 EPS - MarketBeat

Feb 28, 2025

Personalis files to sell 14.04M shares of common stock for holders - MSN

Feb 28, 2025

Personalis stock target cut to $7.00 at Needham, retains buy rating - Investing.com Canada

Feb 28, 2025

Personalis, Inc. (NASDAQ:PSNL) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 28, 2025

A Glimpse Into The Expert Outlook On Personalis Through 7 Analysts - Benzinga

Feb 28, 2025